PDS Biotechnology Corporation (PDSB) financial statements and ratios from SEC XBRL: revenue $1.22M (TTM), net margin -2833.9%, revenue growth -51.6% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.22M |
| Net Margin | -2833.9% |
| Revenue Growth (YoY) | -51.6% |
| EPS Growth (YoY) | -28.2% |
| FCF Growth (YoY) | -20.8% |
| Price / Book | 10.33 |
| Price / Sales | 34.11 |
| FCF Yield | -104.9% |
| Altman Z-Score | -11.44 (distress) |
| Sector P/E (Healthcare) | 21.7 |
PDSB overview · PDSB earnings · PDSB KPIs · PDSB investor relations · PDSB ownership · PDSB peers · PDSB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.